Topical Bevacizumab for Preventing Recurrent Pterygium

Clinical trial NCT01311960 · COMPLETED

Trial details

NCT number: NCT01311960
Sponsor: Chulalongkorn University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pterygium Bevacizumab VEGF Anti-VEGF

Start date: 2010-12-01
Primary completion: 2013-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.